The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Letters to the Editor

Letters to the Editor

July 1, 2007 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

I would have no problem injecting the knee with corticosteroids with an INR (international normalization ratio) around 3. I have injected many joints under these circumstances without any complications (just have an experienced hand perform it). Intravenous (IV) steroids can also be used.

You Might Also Like
  • Letters to the Editor
  • Letters to the Editor
  • Letters to the Editor
Explore This Issue
July 2007
Also By This Author
  • The ACR/ARHP Annual Meeting: Focus on You

I think that steroid use for brief periods is safe (again, from personal experience). How many chronic obstructive pulmonary disease (COPD) patients with exacerbations from pneumonia are given IV steroids without terrible consequences? I feel that steroids are given a bad rap and in short bursts, as used for treating gout—especially with NSAIDs contraindicated—they are a viable option.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

With creatinines of 1.5 to 1.8 in a similar setting, IV colchicine can be tried at 1 mg and possibly repeated in 24 hours. I have used this administrative route many times in the past with good results. The referring attending is always reluctant to use it as well and, unfortunately, formularies are following suit.

Steve Fink, DO, Chief of Rheumatology

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

VA Medical Center, Seminole, Fla.

 

The patient most likely has gout, but he could have a septic knee. I feel you have no choice but to aspirate his knee. I have aspirated and injected hundreds of joints in patients on coumadin. To my knowledge, none has developed a hemarthrosis. Given your patient’s circumstances I would have no problem aspirating his knee. If crystals were seen and the gram stain is negative, I would then treat with intra-articular steroids.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

IV colchicines are not on formulary in many hospitals and a bad idea with elevated creatinine. ACTH is not much different than exogenous steroids, but would be my second option.

James S. Cohen, MD, Rheumatologist

Arthritis Care Center, Indianapolis, Ind.

 

I think I’d vote for an intra-articular injection of steroids as long as some antibiotics were already on board, and I’d strongly consider colchicine 0.6 QOD or Q3D to prevent future flares, as the likely trigger of lasix with congestive heart failure is going to continue. Perhaps the risk of an intra-articular bleed with an INR of 3 is less than the likely morbidity of ensuing inflammation in that knee.

Jonathan Samuels, MD, Director, Clinical Immunology Laboratory

NYU Hospital for Joint Diseases, New York City

 

I would have given IV colchicine, 1 mg x1, to your elderly man with gout on top of multisystem failure.

Ronenn Roubenoff, MD, MHS

Senior Director, Immunology Medical Research

Biogen Idec, Inc., Cambridge, Mass.

 

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Crystal Arthritis Tagged With: Gout, Quality, TreatmentIssue: July 2007

You Might Also Like:
  • Letters to the Editor
  • Letters to the Editor
  • Letters to the Editor
  • Letters to the Editor

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.